AI spots drugs that may be repurposed for priority pathogen

Researchers have used AI algorithms to sift through thousands of drug molecules and identify some with activity against problem pathogen S pneumoniae.

SNIPR phage therapy clears MDR infection in first patient

A kidney transplant patient with a resistant infection is the first to be treated using a bacteriophage therapy developed by Denmark's SNIPR Biome.

EU approves Pfizer antibiotic for superbug infections

Pfizer’s Emblaveo has been approved in the EU with a first-in-class indication in multidrug-resistant (MDR) infections.

GSK reveals data on novel gonorrhoea drug gepotidacin

GSK has unveiled the data for its novel antibiotic gepotidacin as a treatment for gonorrhoea, putting the drug on track to become an important therapy for people with resistant forms

Merck’s last-resort antibiotic Recarbrio nears EU approval

Combating Antifungal Resistance to be discussed at Superbugs...

Antifungal Resistance at Superbugs & Superdrugs 2019